| http://www.w3.org/ns/prov#value | - thereofUS72650964 Nov 20034 Sep 2007Xenoport, Inc.treat or prevent diseases or disorders such as cancer or viral infectionsUS727083120 Mar 200318 Sep 2007Purdue Pharma L.P.Orally administrable opioid formulations having extended duration of effectUS72762503 Jul 20022 Oct 2007Penwest Pharmaceuticals CompanySustained release formulations of oxymorphoneUS728250923 Mar 200516 Oct 2007Aryx Therapeutics
|
